Alnajashi, Hind. 2025. “Ocrelizumab and Rituximab for the Treatment of Multiple Sclerosis Patients: A Real-World Clinical Experience: Comparing Ocrelizumab and Rituximab in MS Treatment”. Journal of Contemporary Medical Sciences 11 (4). https://doi.org/10.22317/jcms.v11i4.1916.